Additionally, when subjects were categorized as ApoE4 carriers and non-carriers, the proportion of ApoE4+ individuals did not significantly differ between AD patients (35.3%) and HC (23.1%) (p = 0.51). The gene discussed is APOE; the disease is Alzheimer disease.